{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T20:50:53Z","timestamp":1781383853580,"version":"3.54.1"},"reference-count":54,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,1]]},"abstract":"\n OBJECTIVE<\/jats:title>\n Primary brain tumors are the most common cause of cancer-related deaths in children and pose difficult questions for the treating physician regarding issues such as the risk\/benefit of performing a biopsy, the accuracy of monitoring methods, and the availability of prognostic indicators. It has been recently shown that tumor-specific DNA and proteins can be successfully isolated in liquid biopsies, and it may be possible to exploit this potential as a particularly useful tool for the clinician in addressing these issues.<\/jats:p>\n <\/jats:sec>\n \n METHODS<\/jats:title>\n A review of the current literature was conducted by searching PubMed and Scopus. MeSH terms for the search included \u201cliquid biopsy,\u201d \u201cbrain,\u201d \u201ctumor,\u201d and \u201cpediatrics\u201d in all fields. Articles were reviewed to identify the type of brain tumor involved, the method of tumor DNA\/protein analysis, and the potential clinical utility. All articles involving primary studies of pediatric brain tumors were included, but reviews were excluded.<\/jats:p>\n <\/jats:sec>\n \n RESULTS<\/jats:title>\n The successful isolation of circulating tumor DNA (ctDNA), extracellular vesicles, and tumor-specific proteins from liquid biopsies has been consistently demonstrated. This most commonly occurs through CSF analysis, but it has also been successfully demonstrated using plasma and urine samples. Tumor-related gene mutations and alterations in protein expression are identifiable and, in some cases, have been correlated to specific neoplasms. The quantity of ctDNA isolated also appears to have a direct relationship with tumor progression and response to treatment.<\/jats:p>\n <\/jats:sec>\n \n CONCLUSIONS<\/jats:title>\n The use of liquid biopsies for the diagnosis and monitoring of primary pediatric brain tumors is a foreseeable possibility, as the requisite developmental steps have largely been demonstrated. Increasingly advanced molecular methods are being developed to improve the identification of tumor subtypes and tumor grades, and they may offer a method for monitoring treatment response. These minimally invasive markers will likely be used in the clinical treatment of pediatric brain tumors in the future.<\/jats:p>\n <\/jats:sec>","DOI":"10.3171\/2019.9.focus19712","type":"journal-article","created":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T18:29:41Z","timestamp":1578076181000},"page":"E8","source":"Crossref","is-referenced-by-count":26,"title":["Liquid biopsies for the diagnosis and surveillance of primary pediatric central nervous system tumors: a review for practicing neurosurgeons"],"prefix":"10.3171","volume":"48","author":[{"given":"Michael T.","family":"Bounajem","sequence":"first","affiliation":[{"name":"Long School of Medicine, University of Texas Health, San Antonio, Texas; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Karsy","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Clinical Neurosciences Center, University of Utah, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randy L.","family":"Jensen","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Clinical Neurosciences Center, University of Utah, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"key":"b1","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"889","DOI":"10.3171\/jns.1981.55.6.0889","article-title":"Pineal tumors in children and adolescents. Treatment by CSF shunting and radiotherapy","volume":"55","author":"Abay EO II","year":"1981","unstructured":"Abay EO II, Laws ER Jr, Grado GL, Bruckman JE, Forbes GS, Gomez MR, : Pineal tumors in children and adolescents. Treatment by CSF shunting and radiotherapy. J Neurosurg 55:889\u2013895, 1981729946310.3171\/jns.1981.55.6.0889"},{"key":"b2","series-title":"Clin Cancer Res","first-page":"1461","article-title":"O6-methyl-guanine-DNA methyltransferase methylation in serum and tumor DNA predicts response to 1,3-bis(2-chloroethyl)-1-nitrosourea but not to temozolamide plus cisplatin in glioblastoma multiforme","volume":"9","author":"Bala\u00f1a C","year":"2003","unstructured":"Bala\u00f1a C, Ramirez JL, Taron M, Roussos Y, Ariza A, Ballester R, : O6-methyl-guanine-DNA methyltransferase methylation in serum and tumor DNA predicts response to 1,3-bis(2-chloroethyl)-1-nitrosourea but not to temozolamide plus cisplatin in glioblastoma multiforme. Clin Cancer Res 9:1461\u20131468, 2003"},{"key":"b3","series-title":"NPJ Precis Oncol","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41698-018-0072-z","article-title":"Liquid biopsy for pediatric central nervous system tumors","volume":"2","author":"Bonner ER","year":"2018","unstructured":"Bonner ER, Bornhorst M, Packer RJ, Nazarian J: Liquid biopsy for pediatric central nervous system tumors. NPJ Precis Oncol 2:29, 201810.1038\/s41698-018-0072-z30588509"},{"key":"b4","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s11060-016-2151-8","article-title":"Pseudoprogression in children, adolescents and young adults with non-brainstem high grade glioma and diffuse intrinsic pontine glioma","volume":"129","author":"Carceller F","year":"2016","unstructured":"Carceller F, Fowkes LA, Khabra K, Moreno L, Saran F, Burford A, : Pseudoprogression in children, adolescents and young adults with non-brainstem high grade glioma and diffuse intrinsic pontine glioma. J Neurooncol 129:109\u2013121, 201610.1007\/s11060-016-2151-8"},{"key":"b5","series-title":"Curr Neurol Neurosci Rep","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11910-016-0629-6","article-title":"The \u201cliquid biopsy\u201d: the role of circulating DNA and RNA in central nervous system tumors","volume":"16","author":"Connolly ID","year":"2016","unstructured":"Connolly ID, Li Y, Gephart MH, Nagpal S: The \u201cliquid biopsy\u201d: the role of circulating DNA and RNA in central nervous system tumors. Curr Neurol Neurosci Rep 16:25, 201610.1007\/s11910-016-0629-6"},{"key":"b6","series-title":"Proteomics","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1002\/pmic.201100499","article-title":"Cerebrospinal fluid top-down proteomics evidenced the potential biomarker role of LVV- and VV-hemorphin-7 in posterior cranial fossa pediatric brain tumors","volume":"12","author":"Desiderio C","year":"2012","unstructured":"Desiderio C, D\u2019Angelo L, Rossetti DV, Iavarone F, Giardina B, Castagnola M, : Cerebrospinal fluid top-down proteomics evidenced the potential biomarker role of LVV- and VV-hemorphin-7 in posterior cranial fossa pediatric brain tumors. Proteomics 12:2158\u20132166, 20122262340110.1002\/pmic.201100499"},{"key":"b7","series-title":"J Clin Oncol","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1200\/JCO.2012.45.2011","article-title":"Liquid biopsies: genotyping circulating tumor DNA","volume":"32","author":"Diaz LA Jr","year":"2014","unstructured":"Diaz LA Jr, Bardelli A: Liquid biopsies: genotyping circulating tumor DNA. J Clin Oncol 32:579\u2013586, 20142444923810.1200\/JCO.2012.45.2011"},{"key":"b8","series-title":"Nat Med","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/nm.1789","article-title":"Circulating mutant DNA to assess tumor dynamics","volume":"14","author":"Diehl F","year":"2008","unstructured":"Diehl F, Schmidt K, Choti MA, Romans K, Goodman S, Li M, : Circulating mutant DNA to assess tumor dynamics. Nat Med 14:985\u2013990, 200810.1038\/nm.178918670422"},{"key":"b9","series-title":"Sci Transl Med","doi-asserted-by":"publisher","first-page":"302ra133","DOI":"10.1126\/scitranslmed.aab0021","article-title":"Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer","volume":"7","author":"Garcia-Murillas I","year":"2015","unstructured":"Garcia-Murillas I, Schiavon G, Weigelt B, Ng C, Hrebien S, Cutts RJ, : Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer. Sci Transl Med 7:302ra133, 201510.1126\/scitranslmed.aab002126311728"},{"key":"b10","series-title":"Acta Neuropathol Commun","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40478-017-0436-6","article-title":"Detection of histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline glioma","volume":"5","author":"Huang TY","year":"2017","unstructured":"Huang TY, Piunti A, Lulla RR, Qi J, Horbinski CM, Tomita T, : Detection of histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline glioma. Acta Neuropathol Commun 5:28, 201710.1186\/s40478-017-0436-628416018"},{"key":"b11","series-title":"Crit Rev Oncol Hematol","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.critrevonc.2018.03.027","article-title":"The identification and isolation of CTCs: a biological Rubik\u2019s cube","volume":"126","author":"Mansilla C","year":"2018","unstructured":"Mansilla C, Soria E, Ram\u00edrez N: The identification and isolation of CTCs: a biological Rubik\u2019s cube. Crit Rev Oncol Hematol 126:129\u2013134, 20182975955410.1016\/j.critrevonc.2018.03.027"},{"issue":"Suppl 1","key":"b12","series-title":"Neuro Oncol","doi-asserted-by":"publisher","first-page":"i1","DOI":"10.1093\/neuonc\/nov297","article-title":"American Brain Tumor Association adolescent and young adult primary brain and central nervous system tumors diagnosed in the United States in 2008-2012","volume":"18","author":"Ostrom QT","year":"2016","unstructured":"Ostrom QT, Gittleman H, de Blank PM, Finlay JL, Gurney JG, McKean-Cowdin R, : American Brain Tumor Association adolescent and young adult primary brain and central nervous system tumors diagnosed in the United States in 2008-2012. Neuro Oncol 18 (Suppl 1):i1\u2013i50, 201610.1093\/neuonc\/nov297"},{"key":"b13","series-title":"Acta Neuropathol","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s00401-018-1936-6","article-title":"Molecular profiling of tumors of the brainstem by sequencing of CSF-derived circulating tumor DNA","volume":"137","author":"Pan C","year":"2019","unstructured":"Pan C, Diplas BH, Chen X, Wu Y, Xiao X, Jiang L, : Molecular profiling of tumors of the brainstem by sequencing of CSF-derived circulating tumor DNA. Acta Neuropathol 137:297\u2013306, 201910.1007\/s00401-018-1936-630460397"},{"key":"b14","series-title":"Clin Cancer Res","doi-asserted-by":"publisher","first-page":"5850","DOI":"10.1158\/1078-0432.CCR-18-1345","article-title":"Clinically relevant and minimally invasive tumor surveillance of pediatric diffuse midline gliomas using patient-derived liquid biopsy","volume":"24","author":"Panditharatna E","year":"2018","unstructured":"Panditharatna E, Kilburn LB, Aboian MS, Kambhampati M, Gordish-Dressman H, Magge SN, : Clinically relevant and minimally invasive tumor surveillance of pediatric diffuse midline gliomas using patient-derived liquid biopsy. Clin Cancer Res 24:5850\u20135859, 201810.1158\/1078-0432.CCR-18-134530322880"},{"key":"b15","series-title":"Neuro Oncol","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1093\/neuonc\/nop066","article-title":"Prevalence estimates for primary brain tumors in the United States by age, gender, behavior, and histology","volume":"12","author":"Porter KR","year":"2010","unstructured":"Porter KR, McCarthy BJ, Freels S, Kim Y, Davis FG: Prevalence estimates for primary brain tumors in the United States by age, gender, behavior, and histology. Neuro Oncol 12:520\u2013527, 201010.1093\/neuonc\/nop06620511189"},{"key":"b16","series-title":"Proteomics","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1002\/pmic.201000198","article-title":"Proteomic profiling of cerebrospinal fluid identifies prostaglandin D2 synthase as a putative biomarker for pediatric medulloblastoma: a pediatric brain tumor consortium study","volume":"11","author":"Rajagopal MU","year":"2011","unstructured":"Rajagopal MU, Hathout Y, MacDonald TJ, Kieran MW, Gururangan S, Blaney SM, : Proteomic profiling of cerebrospinal fluid identifies prostaglandin D2 synthase as a putative biomarker for pediatric medulloblastoma: a pediatric brain tumor consortium study. Proteomics 11:935\u2013943, 20112127167610.1002\/pmic.201000198"},{"key":"b17","series-title":"Neuro Oncol","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1093\/neuonc\/nos067","article-title":"Insights into pediatric diffuse intrinsic pontine glioma through proteomic analysis of cerebrospinal fluid","volume":"14","author":"Saratsis AM","year":"2012","unstructured":"Saratsis AM, Yadavilli S, Magge S, Rood BR, Perez J, Hill DA, : Insights into pediatric diffuse intrinsic pontine glioma through proteomic analysis of cerebrospinal fluid. Neuro Oncol 14:547\u2013560, 201210.1093\/neuonc\/nos06722492959"},{"key":"b18","series-title":"Nat Rev Clin Oncol","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/nrclinonc.2017.14","article-title":"Integrating liquid biopsies into the management of cancer","volume":"14","author":"Siravegna G","year":"2017","unstructured":"Siravegna G, Marsoni S, Siena S, Bardelli A: Integrating liquid biopsies into the management of cancer. Nat Rev Clin Oncol 14:531\u2013548, 20172825200310.1038\/nrclinonc.2017.14"},{"key":"b19","series-title":"Oncotarget","doi-asserted-by":"publisher","first-page":"46177","DOI":"10.18632\/oncotarget.17579","article-title":"Proteomic analysis of cerebrospinal fluid from children with central nervous system tumors identifies candidate proteins relating to tumor metastatic spread","volume":"8","author":"Spreafico F","year":"2017","unstructured":"Spreafico F, Bongarzone I, Pizzamiglio S, Magni R, Taverna E, De Bortoli M, : Proteomic analysis of cerebrospinal fluid from children with central nervous system tumors identifies candidate proteins relating to tumor metastatic spread. Oncotarget 8:46177\u201346190, 20172852681110.18632\/oncotarget.17579"},{"key":"b20","series-title":"Acta Neuropathol Commun","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s40478-018-0580-7","article-title":"CSF H3F3A K27M circulating tumor DNA copy number quantifies tumor growth and in vitro treatment response","volume":"6","author":"Stallard S","year":"2018","unstructured":"Stallard S, Savelieff MG, Wierzbicki K, Mullan B, Miklja Z, Bruzek A, : CSF H3F3A K27M circulating tumor DNA copy number quantifies tumor growth and in vitro treatment response. Acta Neuropathol Commun 6:80, 201810.1186\/s40478-018-0580-730111355"},{"key":"b21","series-title":"Nat Rev Immunol","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nri2567","article-title":"Membrane vesicles as conveyors of immune responses","volume":"9","author":"Th\u00e9ry C","year":"2009","unstructured":"Th\u00e9ry C, Ostrowski M, Segura E: Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 9:581\u2013593, 200910.1038\/nri256719498381"},{"key":"b22","series-title":"Sci Transl Med","doi-asserted-by":"publisher","first-page":"346ra92","DOI":"10.1126\/scitranslmed.aaf6219","article-title":"Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer","volume":"8","author":"Tie J","year":"2016","unstructured":"Tie J, Wang Y, Tomasetti C, Li L, Springer S, Kinde I, : Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer. Sci Transl Med 8:346ra92, 20162738434810.1126\/scitranslmed.aaf6219"},{"key":"b23","series-title":"Sci Rep","doi-asserted-by":"publisher","first-page":"11198","DOI":"10.1038\/srep11198","article-title":"Monitoring response to therapy in melanoma by quantifying circulating tumour DNA with droplet digital PCR for BRAF and NRAS mutations","volume":"5","author":"Tsao SC","year":"2015","unstructured":"Tsao SC, Weiss J, Hudson C, Christophi C, Cebon J, Behren A, : Monitoring response to therapy in melanoma by quantifying circulating tumour DNA with droplet digital PCR for BRAF and NRAS mutations. Sci Rep 5:11198, 201510.1038\/srep1119826095797"},{"key":"b24","series-title":"Cell Mol Neurobiol","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s10571-011-9697-y","article-title":"Brain tumor microvesicles: insights into intercellular communication in the nervous system","volume":"31","author":"van der Vos KE","year":"2011","unstructured":"van der Vos KE, Balaj L, Skog J, Breakefield XO: Brain tumor microvesicles: insights into intercellular communication in the nervous system. Cell Mol Neurobiol 31:949\u2013959, 201110.1007\/s10571-011-9697-y21553248"},{"key":"b25","series-title":"Mol Cancer Res","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1158\/1541-7786.MCR-16-0044","article-title":"Cell-free DNA (cfDNA): Clinical significance and utility in cancer shaped by emerging technologies","volume":"14","author":"Volik S","year":"2016","unstructured":"Volik S, Alcaide M, Morin RD, Collins C: Cell-free DNA (cfDNA): Clinical significance and utility in cancer shaped by emerging technologies. Mol Cancer Res 14:898\u2013908, 201610.1158\/1541-7786.MCR-16-004427422709"},{"key":"b26","series-title":"Cancer Med","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/cam4.978","article-title":"A comparison of ddPCR and ARMS for detecting EGFR T790M status in ctDNA from advanced NSCLC patients with acquired EGFR-TKI resistance","volume":"6","author":"Wang W","year":"2017","unstructured":"Wang W, Song Z, Zhang Y: A comparison of ddPCR and ARMS for detecting EGFR T790M status in ctDNA from advanced NSCLC patients with acquired EGFR-TKI resistance. Cancer Med 6:154\u2013162, 20172800038710.1002\/cam4.978"},{"key":"b27","series-title":"Proc Natl Acad Sci U S A","doi-asserted-by":"publisher","first-page":"9704","DOI":"10.1073\/pnas.1511694112","article-title":"Detection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cord","volume":"112","author":"Wang Y","year":"2015","unstructured":"Wang Y, Springer S, Zhang M, McMahon KW, Kinde I, Dobbyn L, : Detection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cord. Proc Natl Acad Sci U S A 112:9704\u20139709, 201510.1073\/pnas.151169411226195750"},{"key":"b1","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"889","DOI":"10.3171\/jns.1981.55.6.0889","article-title":"Pineal tumors in children and adolescents. Treatment by CSF shunting and radiotherapy","volume":"55","author":"Abay EO II","year":"1981","unstructured":"Abay EO II, Laws ER Jr, Grado GL, Bruckman JE, Forbes GS, Gomez MR, : Pineal tumors in children and adolescents. Treatment by CSF shunting and radiotherapy. J Neurosurg 55:889\u2013895, 1981729946310.3171\/jns.1981.55.6.0889"},{"key":"b2","series-title":"Clin Cancer Res","first-page":"1461","article-title":"O6-methyl-guanine-DNA methyltransferase methylation in serum and tumor DNA predicts response to 1,3-bis(2-chloroethyl)-1-nitrosourea but not to temozolamide plus cisplatin in glioblastoma multiforme","volume":"9","author":"Bala\u00f1a C","year":"2003","unstructured":"Bala\u00f1a C, Ramirez JL, Taron M, Roussos Y, Ariza A, Ballester R, : O6-methyl-guanine-DNA methyltransferase methylation in serum and tumor DNA predicts response to 1,3-bis(2-chloroethyl)-1-nitrosourea but not to temozolamide plus cisplatin in glioblastoma multiforme. Clin Cancer Res 9:1461\u20131468, 2003"},{"key":"b3","series-title":"NPJ Precis Oncol","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41698-018-0072-z","article-title":"Liquid biopsy for pediatric central nervous system tumors","volume":"2","author":"Bonner ER","year":"2018","unstructured":"Bonner ER, Bornhorst M, Packer RJ, Nazarian J: Liquid biopsy for pediatric central nervous system tumors. NPJ Precis Oncol 2:29, 201810.1038\/s41698-018-0072-z30588509"},{"key":"b4","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s11060-016-2151-8","article-title":"Pseudoprogression in children, adolescents and young adults with non-brainstem high grade glioma and diffuse intrinsic pontine glioma","volume":"129","author":"Carceller F","year":"2016","unstructured":"Carceller F, Fowkes LA, Khabra K, Moreno L, Saran F, Burford A, : Pseudoprogression in children, adolescents and young adults with non-brainstem high grade glioma and diffuse intrinsic pontine glioma. J Neurooncol 129:109\u2013121, 201610.1007\/s11060-016-2151-8"},{"key":"b5","series-title":"Curr Neurol Neurosci Rep","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11910-016-0629-6","article-title":"The \u201cliquid biopsy\u201d: the role of circulating DNA and RNA in central nervous system tumors","volume":"16","author":"Connolly ID","year":"2016","unstructured":"Connolly ID, Li Y, Gephart MH, Nagpal S: The \u201cliquid biopsy\u201d: the role of circulating DNA and RNA in central nervous system tumors. Curr Neurol Neurosci Rep 16:25, 201610.1007\/s11910-016-0629-6"},{"key":"b6","series-title":"Proteomics","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1002\/pmic.201100499","article-title":"Cerebrospinal fluid top-down proteomics evidenced the potential biomarker role of LVV- and VV-hemorphin-7 in posterior cranial fossa pediatric brain tumors","volume":"12","author":"Desiderio C","year":"2012","unstructured":"Desiderio C, D\u2019Angelo L, Rossetti DV, Iavarone F, Giardina B, Castagnola M, : Cerebrospinal fluid top-down proteomics evidenced the potential biomarker role of LVV- and VV-hemorphin-7 in posterior cranial fossa pediatric brain tumors. Proteomics 12:2158\u20132166, 20122262340110.1002\/pmic.201100499"},{"key":"b7","series-title":"J Clin Oncol","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1200\/JCO.2012.45.2011","article-title":"Liquid biopsies: genotyping circulating tumor DNA","volume":"32","author":"Diaz LA Jr","year":"2014","unstructured":"Diaz LA Jr, Bardelli A: Liquid biopsies: genotyping circulating tumor DNA. J Clin Oncol 32:579\u2013586, 20142444923810.1200\/JCO.2012.45.2011"},{"key":"b8","series-title":"Nat Med","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/nm.1789","article-title":"Circulating mutant DNA to assess tumor dynamics","volume":"14","author":"Diehl F","year":"2008","unstructured":"Diehl F, Schmidt K, Choti MA, Romans K, Goodman S, Li M, : Circulating mutant DNA to assess tumor dynamics. Nat Med 14:985\u2013990, 200810.1038\/nm.178918670422"},{"key":"b9","series-title":"Sci Transl Med","doi-asserted-by":"publisher","first-page":"302ra133","DOI":"10.1126\/scitranslmed.aab0021","article-title":"Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer","volume":"7","author":"Garcia-Murillas I","year":"2015","unstructured":"Garcia-Murillas I, Schiavon G, Weigelt B, Ng C, Hrebien S, Cutts RJ, : Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer. Sci Transl Med 7:302ra133, 201510.1126\/scitranslmed.aab002126311728"},{"key":"b10","series-title":"Acta Neuropathol Commun","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40478-017-0436-6","article-title":"Detection of histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline glioma","volume":"5","author":"Huang TY","year":"2017","unstructured":"Huang TY, Piunti A, Lulla RR, Qi J, Horbinski CM, Tomita T, : Detection of histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline glioma. Acta Neuropathol Commun 5:28, 201710.1186\/s40478-017-0436-628416018"},{"key":"b11","series-title":"Crit Rev Oncol Hematol","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.critrevonc.2018.03.027","article-title":"The identification and isolation of CTCs: a biological Rubik\u2019s cube","volume":"126","author":"Mansilla C","year":"2018","unstructured":"Mansilla C, Soria E, Ram\u00edrez N: The identification and isolation of CTCs: a biological Rubik\u2019s cube. Crit Rev Oncol Hematol 126:129\u2013134, 20182975955410.1016\/j.critrevonc.2018.03.027"},{"issue":"Suppl 1","key":"b12","series-title":"Neuro Oncol","doi-asserted-by":"publisher","first-page":"i1","DOI":"10.1093\/neuonc\/nov297","article-title":"American Brain Tumor Association adolescent and young adult primary brain and central nervous system tumors diagnosed in the United States in 2008-2012","volume":"18","author":"Ostrom QT","year":"2016","unstructured":"Ostrom QT, Gittleman H, de Blank PM, Finlay JL, Gurney JG, McKean-Cowdin R, : American Brain Tumor Association adolescent and young adult primary brain and central nervous system tumors diagnosed in the United States in 2008-2012. Neuro Oncol 18 (Suppl 1):i1\u2013i50, 201610.1093\/neuonc\/nov297"},{"key":"b13","series-title":"Acta Neuropathol","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s00401-018-1936-6","article-title":"Molecular profiling of tumors of the brainstem by sequencing of CSF-derived circulating tumor DNA","volume":"137","author":"Pan C","year":"2019","unstructured":"Pan C, Diplas BH, Chen X, Wu Y, Xiao X, Jiang L, : Molecular profiling of tumors of the brainstem by sequencing of CSF-derived circulating tumor DNA. Acta Neuropathol 137:297\u2013306, 201910.1007\/s00401-018-1936-630460397"},{"key":"b14","series-title":"Clin Cancer Res","doi-asserted-by":"publisher","first-page":"5850","DOI":"10.1158\/1078-0432.CCR-18-1345","article-title":"Clinically relevant and minimally invasive tumor surveillance of pediatric diffuse midline gliomas using patient-derived liquid biopsy","volume":"24","author":"Panditharatna E","year":"2018","unstructured":"Panditharatna E, Kilburn LB, Aboian MS, Kambhampati M, Gordish-Dressman H, Magge SN, : Clinically relevant and minimally invasive tumor surveillance of pediatric diffuse midline gliomas using patient-derived liquid biopsy. Clin Cancer Res 24:5850\u20135859, 201810.1158\/1078-0432.CCR-18-134530322880"},{"key":"b15","series-title":"Neuro Oncol","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1093\/neuonc\/nop066","article-title":"Prevalence estimates for primary brain tumors in the United States by age, gender, behavior, and histology","volume":"12","author":"Porter KR","year":"2010","unstructured":"Porter KR, McCarthy BJ, Freels S, Kim Y, Davis FG: Prevalence estimates for primary brain tumors in the United States by age, gender, behavior, and histology. Neuro Oncol 12:520\u2013527, 201010.1093\/neuonc\/nop06620511189"},{"key":"b16","series-title":"Proteomics","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1002\/pmic.201000198","article-title":"Proteomic profiling of cerebrospinal fluid identifies prostaglandin D2 synthase as a putative biomarker for pediatric medulloblastoma: a pediatric brain tumor consortium study","volume":"11","author":"Rajagopal MU","year":"2011","unstructured":"Rajagopal MU, Hathout Y, MacDonald TJ, Kieran MW, Gururangan S, Blaney SM, : Proteomic profiling of cerebrospinal fluid identifies prostaglandin D2 synthase as a putative biomarker for pediatric medulloblastoma: a pediatric brain tumor consortium study. Proteomics 11:935\u2013943, 20112127167610.1002\/pmic.201000198"},{"key":"b17","series-title":"Neuro Oncol","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1093\/neuonc\/nos067","article-title":"Insights into pediatric diffuse intrinsic pontine glioma through proteomic analysis of cerebrospinal fluid","volume":"14","author":"Saratsis AM","year":"2012","unstructured":"Saratsis AM, Yadavilli S, Magge S, Rood BR, Perez J, Hill DA, : Insights into pediatric diffuse intrinsic pontine glioma through proteomic analysis of cerebrospinal fluid. Neuro Oncol 14:547\u2013560, 201210.1093\/neuonc\/nos06722492959"},{"key":"b18","series-title":"Nat Rev Clin Oncol","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/nrclinonc.2017.14","article-title":"Integrating liquid biopsies into the management of cancer","volume":"14","author":"Siravegna G","year":"2017","unstructured":"Siravegna G, Marsoni S, Siena S, Bardelli A: Integrating liquid biopsies into the management of cancer. Nat Rev Clin Oncol 14:531\u2013548, 20172825200310.1038\/nrclinonc.2017.14"},{"key":"b19","series-title":"Oncotarget","doi-asserted-by":"publisher","first-page":"46177","DOI":"10.18632\/oncotarget.17579","article-title":"Proteomic analysis of cerebrospinal fluid from children with central nervous system tumors identifies candidate proteins relating to tumor metastatic spread","volume":"8","author":"Spreafico F","year":"2017","unstructured":"Spreafico F, Bongarzone I, Pizzamiglio S, Magni R, Taverna E, De Bortoli M, : Proteomic analysis of cerebrospinal fluid from children with central nervous system tumors identifies candidate proteins relating to tumor metastatic spread. Oncotarget 8:46177\u201346190, 20172852681110.18632\/oncotarget.17579"},{"key":"b20","series-title":"Acta Neuropathol Commun","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s40478-018-0580-7","article-title":"CSF H3F3A K27M circulating tumor DNA copy number quantifies tumor growth and in vitro treatment response","volume":"6","author":"Stallard S","year":"2018","unstructured":"Stallard S, Savelieff MG, Wierzbicki K, Mullan B, Miklja Z, Bruzek A, : CSF H3F3A K27M circulating tumor DNA copy number quantifies tumor growth and in vitro treatment response. Acta Neuropathol Commun 6:80, 201810.1186\/s40478-018-0580-730111355"},{"key":"b21","series-title":"Nat Rev Immunol","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nri2567","article-title":"Membrane vesicles as conveyors of immune responses","volume":"9","author":"Th\u00e9ry C","year":"2009","unstructured":"Th\u00e9ry C, Ostrowski M, Segura E: Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 9:581\u2013593, 200910.1038\/nri256719498381"},{"key":"b22","series-title":"Sci Transl Med","doi-asserted-by":"publisher","first-page":"346ra92","DOI":"10.1126\/scitranslmed.aaf6219","article-title":"Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer","volume":"8","author":"Tie J","year":"2016","unstructured":"Tie J, Wang Y, Tomasetti C, Li L, Springer S, Kinde I, : Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer. Sci Transl Med 8:346ra92, 20162738434810.1126\/scitranslmed.aaf6219"},{"key":"b23","series-title":"Sci Rep","doi-asserted-by":"publisher","first-page":"11198","DOI":"10.1038\/srep11198","article-title":"Monitoring response to therapy in melanoma by quantifying circulating tumour DNA with droplet digital PCR for BRAF and NRAS mutations","volume":"5","author":"Tsao SC","year":"2015","unstructured":"Tsao SC, Weiss J, Hudson C, Christophi C, Cebon J, Behren A, : Monitoring response to therapy in melanoma by quantifying circulating tumour DNA with droplet digital PCR for BRAF and NRAS mutations. Sci Rep 5:11198, 201510.1038\/srep1119826095797"},{"key":"b24","series-title":"Cell Mol Neurobiol","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s10571-011-9697-y","article-title":"Brain tumor microvesicles: insights into intercellular communication in the nervous system","volume":"31","author":"van der Vos KE","year":"2011","unstructured":"van der Vos KE, Balaj L, Skog J, Breakefield XO: Brain tumor microvesicles: insights into intercellular communication in the nervous system. Cell Mol Neurobiol 31:949\u2013959, 201110.1007\/s10571-011-9697-y21553248"},{"key":"b25","series-title":"Mol Cancer Res","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1158\/1541-7786.MCR-16-0044","article-title":"Cell-free DNA (cfDNA): Clinical significance and utility in cancer shaped by emerging technologies","volume":"14","author":"Volik S","year":"2016","unstructured":"Volik S, Alcaide M, Morin RD, Collins C: Cell-free DNA (cfDNA): Clinical significance and utility in cancer shaped by emerging technologies. Mol Cancer Res 14:898\u2013908, 201610.1158\/1541-7786.MCR-16-004427422709"},{"key":"b26","series-title":"Cancer Med","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/cam4.978","article-title":"A comparison of ddPCR and ARMS for detecting EGFR T790M status in ctDNA from advanced NSCLC patients with acquired EGFR-TKI resistance","volume":"6","author":"Wang W","year":"2017","unstructured":"Wang W, Song Z, Zhang Y: A comparison of ddPCR and ARMS for detecting EGFR T790M status in ctDNA from advanced NSCLC patients with acquired EGFR-TKI resistance. Cancer Med 6:154\u2013162, 20172800038710.1002\/cam4.978"},{"key":"b27","series-title":"Proc Natl Acad Sci U S A","doi-asserted-by":"publisher","first-page":"9704","DOI":"10.1073\/pnas.1511694112","article-title":"Detection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cord","volume":"112","author":"Wang Y","year":"2015","unstructured":"Wang Y, Springer S, Zhang M, McMahon KW, Kinde I, Dobbyn L, : Detection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cord. Proc Natl Acad Sci U S A 112:9704\u20139709, 201510.1073\/pnas.151169411226195750"}],"container-title":["Neurosurgical Focus"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/neurosurg-focus\/48\/1\/article-pE8.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/neurosurg-focus\/48\/1\/article-pE8.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/neurosurg-focus\/48\/1\/article-pE8.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T08:38:00Z","timestamp":1778315880000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/neurosurg-focus\/48\/1\/article-pE8.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":54,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3171\/2019.9.focus19712","relation":{},"ISSN":["1092-0684"],"issn-type":[{"value":"1092-0684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1]]}}}